CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities
Net loss	$ (18,399)	$ (36,258)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	1,523	1,952
Stock-based compensation	17,363	15,368
Non-cash operating lease cost	1,929	1,563
Net loss on sale of available-for-sale securities	4	50
Unrealized gain on investments	(218)	(1)
Loss on disposal of fixed assets	3
Impairment charges for facilities consolidation		1,698
Non-cash interest expense	297	290
Foreign currency remeasurement gain	(141)	(1,396)
Changes in operating assets and liabilities:
Accounts receivable	11,128	9,687
Inventories	8,020	(19,519)
Prepaid and other assets	(2,188)	(1,509)
Accounts payable	(7,825)	8,089
Accrued liabilities and other non-current liabilities	(4,886)	(8,346)
Deferred revenue	(180)	347
Net cash provided by (used in) operating activities	6,430	(27,985)
Investing activities
Capital expenditures	(1,861)	(4,603)
Purchases of investments	(18,741)	(2,404)
Proceeds from maturities and sale of investments	19,758	7,415
Net cash (used in) provided by investing activities	(844)	408
Financing activities
Net proceeds from equity incentives	804	925
Net costs from public offerings	(107)	(137)
Net (payment on) proceeds from revolving line of credit	(1,479)	3,870
Proceeds from loans	5,000	5,000
Debt issuance costs		(168)
Net cash provided by financing activities	4,218	9,490
Effect of exchange rates on cash, cash equivalents, and restricted cash	46	(112)
Net increase (decrease) in cash, cash equivalents, and restricted cash	9,850	(18,199)
Cash, cash equivalents, and restricted cash, beginning of period	13,359	37,358
Cash, cash equivalents, and restricted cash, end of period	$ 23,209	$ 19,159